Essai de prévention des encephalopathies à Loa loa post-ivermectine par l'administration d'une faible dose initiale
FR
CHATENAY M.-PARIS 11-BU Pharma. (920192101) / Sudoc / Sudoc / France / FR
NANCY1-SCD Pharmacie-Odontologie (543952101) / Sudoc / Sudoc / France / FR
FR
A clinical trail was conducted in 2 health centers in northern Cameroon to assess the safety and efficacy of a new polyvalent antivenom composed of higly purified and pasteurized F(ab')2 (FAV-Africa). Forty-six patients with objective signs of envenomation, including 67% with hemorrhage, were included in the study. Each patient received at least 20...